Company
Headquarters: Hemel Hempstead, United Kingdom
CEO: Mr. Menachem Cohen
₪43.2 Million
ILS as of Aug. 1, 2021
US$13.4 Million
| Company | Market Cap (USD) |
|---|---|
| Intuitive Surgical, Inc. | $113.81 B |
| EssilorLuxottica SA | $90.57 B |
| Becton, Dickinson and Company | $70.33 B |
| HOYA Corp | $43.39 B |
| Alcon Inc. | $37.65 B |
| Company | Market Cap (USD) |
|---|---|
| Lilly | $586.39 B |
| UnitedHealth Group | $504.47 B |
| Novo Nordisk | $461.52 B |
| Johnson & Johnson | $387.50 B |
| Merck | $296.51 B |
Medivie Therapeutic Limited develops and markets dental devices. It offers Laboraide, a dental device that is placed between the woman's lower and upper jaw during birth, which allows the relaxation of the jaw, neck, and head muscles through the flow of oxygen to the muscles. The company also develops modular pacifiers that enables development of mouth structure and prevent future damage to the child's gingival structure and teeth. Its product has applications in the areas of birth, migraines, chronic pains, and improving concentration and cognitive activity. The company markets and distributes its products through a network of distributors, as well as online in the Asia, Latin America, the United States, Europe, and Canada. Medivie Therapeutic Limited was founded in 2012 and is based in Hemel Hempstead, the United Kingdom.
Top 1-year algo backtest: +269.94%
$10,000 in May 2023 would now be $36,994 by following this algorithm daily at market close.
Boost your stocks returns with Disfold AI... Now!
Try Disfold AI for FREE
Medivie Therapeutic Ltd has the following listings and related stock indices.
Stock: TASE: MDVI wb_incandescent